Company profile for Adaptive Biotechnologies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are pioneers in immune-driven medicine, empowered by scientific mastery, and fueled by our foresight and curiosity about the adaptive immune system. We’ve spent years laying the scientific and technological groundwork to be the experts on the adaptive immune system. With our partners, we’ve spearheaded the discovery and development of its vast applications across healthcare —and it’s just the beginning. We empower o...
We are pioneers in immune-driven medicine, empowered by scientific mastery, and fueled by our foresight and curiosity about the adaptive immune system. We’ve spent years laying the scientific and technological groundwork to be the experts on the adaptive immune system. With our partners, we’ve spearheaded the discovery and development of its vast applications across healthcare —and it’s just the beginning. We empower our partners in the academic and biopharmaceutical communities with our platform, products, services, and data. Together, we’re helping to advance the field of immune-driven medicine.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1551 Eastlake Ave E, Ste 200 Seattle, WA 98102
Telephone
Telephone
+1 206-659-0067
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/15/3205383/0/en/Adaptive-Biotechnologies-Announces-Two-Immune-Receptor-Licensing-Agreements-with-Pfizer.html

GLOBENEWSWIRE
15 Dec 2025

https://www.globenewswire.com/news-release/2025/12/09/3202823/0/en/Adaptive-Biotechnologies-to-Participate-in-Jefferies-Fireside-Chat-Series-on-Minimal-Residual-Disease.html

GLOBENEWSWIRE
09 Dec 2025

https://www.globenewswire.com/news-release/2025/12/06/3201053/0/en/Adaptive-Biotechnologies-Showcases-Leadership-in-Hematology-Oncology-MRD-with-New-clonoSEQ-Data-Driving-Treatment-Interventions-at-2025-ASH-Annual-Meeting.html

GLOBENEWSWIRE
06 Dec 2025

https://www.globenewswire.com/news-release/2025/11/24/3193393/0/en/Adaptive-Biotechnologies-Announces-Nearly-90-Abstracts-Featuring-clonoSEQ-MRD-Testing-Across-a-Range-of-Blood-Cancers-to-be-Presented-at-the-67th-ASH-Annual-Meeting.html

GLOBENEWSWIRE
24 Nov 2025
Adaptive Bio To Join Investor Conferences
Adaptive Bio To Join Investor Conferences

06 Nov 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/11/06/3183109/0/en/Adaptive-Biotechnologies-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181968/0/en/Adaptive-Biotechnologies-Reports-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
05 Nov 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty